Please assess the completion status of the following clinical trial:

Trial Title: Transversus Abdominis Plane (TAP) Block Laparoscopic Hysterectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age: 18-64 years~* Surgery: Laparoscopic Hysterectomy surgery~* ASA status: I and II~* Fluent in English~Exclusion Criteria:~* History of allergy to local anesthetics~* History of chronic opioid use~* Pregnant patients~* BMI greater than 30~Drop-out criteria:~* Patient or surgeon request~* Complications related to the procedure

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): sterile normal saline as placebo
- Drug .5% Ropivacaine (Type: ACTIVE_COMPARATOR): Instillation of 20 cc of 0.5% ropivacaine
- 20 cc of 0.25% ropivacaine (Type: ACTIVE_COMPARATOR): Instillation of 20 cc of 0.25% ropivacaine

Based on this trial design, predict the completion outcome and termination type (if applicable).